title: Bullous acral erythema and concomitant pigmentation on the face and occluded skin.
authors.forename: E
authors.initials: E
authors.lastname: Ozkaya-Bayazit
authors.forename: R
authors.initials: R
authors.lastname: Diz-Küçükkaya
authors.forename: E
authors.initials: E
authors.lastname: Akasya
authors.forename: N
authors.initials: N
authors.lastname: Büyükbabani
authors.forename: S
authors.initials: S
authors.lastname: Oncü
authors.forename: Y
authors.initials: Y
authors.lastname: Pekçelen
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D016572:Cyclosporine / Q000008:administration & dosage / Q000009:adverse effects; D003561:Cytarabine / Q000008:administration & dosage / Q000009:adverse effects; D003630:Daunorubicin / Q000008:administration & dosage / Q000009:adverse effects; D003875:Drug Eruptions / Q000209:etiology / Q000473:pathology*; D004890:Erythema / Q000139:chemically induced*; D005260:Female; D006229:Hand Dermatoses / Q000139:chemically induced*; D006801:Humans; D017495:Hyperpigmentation / Q000139:chemically induced*; D007951:Leukemia, Myeloid / Q000188:drug therapy*; D012872:Skin Diseases, Vesiculobullous / Q000139:chemically induced*
chemical_list: D003561:Cytarabine; D016572:Cyclosporine; D003630:Daunorubicin